ANI Pharmaceuticals 

€54.5
16
+€0+0% Friday 13:29

统计数据

当日最高
54.5
当日最低
54
52周最高
-
52周最低
-
成交量
0
平均成交量
-
市值
1.24B
市盈率
-
股息收益率
-
股息
-

即将到来

收益

6Nov预期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一个
0.36
0.67
0.97
1.28
预期每股收益
1.1
实际每股收益
N/A

人们还关注

此列表基于关注BSFA.F的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations, including extended release and combination products. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Show more...
首席执行官
Mr. Nikhil Lalwani
员工
600
国家
US
ISIN
US00182C1036
WKN
000A1W15D

上市公司